1. Inici
  2. Publicacions
  3. Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma.

Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma.

Data de publicació: Data Ahead of Print:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Duraj T
  • García-Romero N
  • Carrión-Navarro J
  • Madurga R
  • Mendivil AO
  • Garcia-Cañamaque L
  • Ayuso-Sacido A

Grups d'Investigació

Abstract

Glioblastoma (GBM) is the most aggressive primary brain tumor, with a median survival at diagnosis of 16-20 months. Metabolism represents a new attractive therapeutic target; however, due to high intratumoral heterogeneity, the application of metabolic drugs in GBM is challenging. We characterized the basal bioenergetic metabolism and antiproliferative potential of metformin (MF), dichloroacetate (DCA), sodium oxamate (SOD) and diazo-5-oxo-L-norleucine (DON) in three distinct glioma stem cells (GSCs) (GBM18, GBM27, GBM38), as well as U87MG. GBM27, a highly oxidative cell line, was the most resistant to all treatments, except DON. GBM18 and GBM38, Warburg-like GSCs, were sensitive to MF and DCA, respectively. Resistance to DON was not correlated with basal metabolic phenotypes. In combinatory experiments, radiomimetic bleomycin exhibited therapeutically relevant synergistic effects with MF, DCA and DON in GBM27 and DON in all other cell lines. MF and DCA shifted the metabolism of treated cells towards glycolysis or oxidation, respectively. DON consistently decreased total ATP production. Our study highlights the need for a better characterization of GBM from a metabolic perspective. Metabolic therapy should focus on both glycolytic and oxidative subpopulations of GSCs.

Dades de la publicació

ISSN/ISSNe:
2073-4409, 2073-4409

Cells  MDPI

Tipus:
Article
Pàgines:
-
PubMed:
33498369
Factor d'Impacte:
1,452 SCImago ℠
Quartil:
Q1 SCImago ℠

Cites Rebudes en Web of Science: 51

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • energy metabolism, gene expression profiling, glioblastoma, glycolysis, oxidative phosphorylation, therapeutics

Projectes associats

EVALUACIÓN DEL ÍNDICE DE PROLIFERACIÓN KI-67 COMO PREDICTOR DE RECIDIVA EN MENINGIOMAS CEREBRALES GRADO I DE LA OMS. COMPARACIÓN CON LA ESCALA DE RESECCIÓN QUIRÚRGICA DE SIMPSON.

Investigador Principal: LUIS RICARDO PRAT ACÍN

2013_0041_CRC_PRAT . FUNDACION MUTUA MADRILEÑA . 2013

ESTUDIO OBSERVACIONAL PROSPECTIVO ACERCA DEL MANEJO PERIOPERATORIO / PERIPROCEDIMIENTO DE LOS FÁRMACOS ANTITROMBÓTICOS EN EL “MUNDO REAL”: REGISTRO REQXAA.

Investigador Principal: RAQUEL FERRANDIS COMES

SEC-API-2019-01 . 2021

Compartir la publicació